Genetic Medico-Diagnostic Laboratory Genica , Sofia , Bulgaria.
Clinic of Nervous Diseases, UMBAL Aleksandrovska , Sofia , Bulgaria.
Amyloid. 2019 Dec;26(4):181-185. doi: 10.1080/13506129.2019.1634539. Epub 2019 Jul 29.
Hereditary transthyretin amyloidosis is an autosomal dominant genetic disorder caused by missense mutations in the gene resulting in amyloid formation of the transthyretin protein. Depending on the system affection, the manifestations may be different and high heterogeneity in the penetrance is observed. An endemic region in Bulgaria exists where the mutation Glu89Gln is found with high frequency. This is a rare mutation and was probably introduced in the population by a common ancestor. This phenomenon, called "founder effect" was proved in carrier families by haplotype analysis of microsatellite markers showing linkage disequilibrium. Allele frequencies were analyzed and haplotype reconstruction was done with Arlequin v.3.01 software. The common ancestry of the carriers was demonstrated using additional data for their genealogies and microsatellite data from a control group of non-affected individuals. The results show that the mutation Glu89Gln is linked to one haplotype, called "hypothetical founder haplotype" which was compared to published haplotype data from other European patients and no similarity was found. Further population genetics studies of carriers of the Glu89Gln mutation from other endemic regions are required in order to clarify the geographical distribution of the mutation.
遗传性转甲状腺素蛋白淀粉样变性是一种常染色体显性遗传疾病,由 基因突变引起,导致转甲状腺素蛋白淀粉样形成。根据受累系统的不同,临床表现可能不同,并且观察到外显率存在高度异质性。保加利亚存在一个地方性流行区域,该区域发现 突变 Glu89Gln 的频率很高。这是一种罕见的突变,可能是由一个共同的祖先引入该人群的。这种现象被称为“奠基者效应”,通过微卫星标记的单体型分析在携带者家族中得到了证明,显示出连锁不平衡。对等位基因频率进行了分析,并使用 Arlequin v.3.01 软件进行了单体型重建。通过对携带者的系谱和非受影响个体的对照组的微卫星数据的附加数据进行分析,证明了携带者的共同祖先。结果表明,突变 Glu89Gln 与一个单体型相关,称为“假设的奠基者单体型”,与其他欧洲患者的已发表单体型数据进行了比较,没有发现相似性。为了阐明突变的地理分布,需要对来自其他地方性流行区域的 Glu89Gln 突变携带者进行进一步的群体遗传学研究。